EC77/2020/L4 Belgium:There are some paras where the wording is ‘non-stigma’. A couple of paras have been agreed in informals pending on the solution of non-stigmatisation. Chair: Canada was the state proposing language on stigma Canada: If we are going to focus on PPs first we did have discussions during informals. Linking PP that references stigma …
El Salvador
Opening of the 63rd Session of the Commission on Narcotic Drugs
*** MORNING SESSION *** Chair: Welcome to CND63. I welcome Chief of UNODC Medical Service to talk about coronavirus. Dr: WHO has introduced guidelines on COVID19 outbreak. Measures to make and keep up safe. Latest numbers: quite a big number of people affected – mainly in China. Now more in other countries than China alone. Main …
Item 15. Provisional agenda for the sixty-third session of the Commission
El Salvador: I have a question about 6A? Will we dealing with the review or the commitments. Under item 5 with the international control treaties we dill with each sub-paragraph, so how would 6B for all the commitments, then B for the review? Secretariat: My understanding that item 6 would be much more comprehensive and …
Committee of the Whole, L8. Enhancing the capacity of Member States to ensure the availability of controlled substances
OP 1 Russia: Providing assistance to states for assessing needs and necessary information to control substances for legitimate purposes, in relation to the title, we have no specific proposal we are ready to accept the title as it is on the screen. Nonetheless we would like to examine the text. Spain: there are three separate …
Plenary: Item 4. General debate of the ministerial segment (cont…)
Chair: Good morning, we’ll now resume the session. We have many on the list. Secretary: We have nearly 70 speakers left that have asked for the floor. We will do our very best – but we’ll have to have another evening session tonight to accommodate. We’d like to appeal to the speakers – some of …
CND intersessional meeting, 26 september 2018: Access to controlled substances for medical and scientific purposes
Chair: Good Morning. Let’s start right away with the presentations and take advantage of the opportunity to conduct interactive sessions. PANEL: Dr. Gilberto Gerra, Chief of Drug Prevention and Health Branch, UNODC: Access to controlled drugs for medical purposes while preventing misuse and diversion. For long time this aspect was not paid attention so now …